We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$113M
2
INTC icon
Intel
INTC
+$61.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.3M
4
CLX icon
Clorox
CLX
+$25.2M
5
TJX icon
TJX Companies
TJX
+$24.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
226
Goldman Sachs
GS
$313B
$3.38M 0.09%
18,768
-2,891
-13% -$537K
EA icon
227
Electronic Arts
EA
$52.4B
$3.35M 0.09%
48,770
-100,017
-67% -$7.02M
SNI
228
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$3.29M 0.09%
59,511
-115,141
-66% -$6.48M
DVN icon
229
Devon Energy
DVN
$51.9B
$3.24M 0.09%
101,265
+11,280
+13% +$463K
IMGN
230
DELISTED
Immunogen Inc
IMGN
$3.23M 0.09%
238,100
– –
TECH icon
231
Bio-Techne
TECH
$11.2B
$3.16M 0.08%
140,440
+12,000
+9% +$274K
DD icon
232
DuPont de Nemours
DD
$18.6B
$3.11M 0.08%
23,832
+11
+0% +$1.41K
BCE icon
233
BCE
BCE
$19.9B
$3.11M 0.08%
80,695
-7,420
-8% -$313K
PX
234
DELISTED
Praxair Inc
PX
$3.09M 0.08%
30,155
-87,515
-74% -$9.55M
SBAC icon
235
SBA Communications
SBAC
$18.4B
$3.03M 0.08%
28,853
-1,827
-6% -$198K
AGIO icon
236
Agios Pharmaceuticals
AGIO
$2.16B
$3.02M 0.08%
46,600
– –
TFCFA
237
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$3.02M 0.08%
111,341
-8,840
-7% -$256K
MDLZ icon
238
Mondelez International
MDLZ
$77.7B
$3.02M 0.08%
67,289
-51,652
-43% -$2.31M
AMT icon
239
American Tower
AMT
$77.7B
$3.01M 0.08%
31,085
-815
-3% -$79.4K
EXPE icon
240
Expedia Group
EXPE
$31.2B
$3.01M 0.08%
24,194
-55,820
-70% -$7.07M
HUM icon
241
Humana
HUM
$46.7B
$2.95M 0.08%
16,550
-1,115
-6% -$196K
EPZM
242
DELISTED
Epizyme, Inc
EPZM
$2.9M 0.08%
181,000
+25,000
+16% +$371K
SU icon
243
Suncor Energy
SU
$77.7B
$2.88M 0.08%
112,155
-19,108
-15% -$528K
GLW icon
244
Corning
GLW
$126B
$2.87M 0.08%
157,231
-782,489
-83% -$14.2M
OMED
245
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.83M 0.08%
125,700
+35,000
+39% +$717K
RAI
246
DELISTED
Reynolds American Inc
RAI
$2.83M 0.08%
61,300
-10,401
-15% -$481K
TGTX icon
247
TG Therapeutics
TGTX
$8.58B
$2.82M 0.08%
236,200
-25,000
-10% -$316K
CRM icon
248
Salesforce
CRM
$134B
$2.81M 0.08%
35,830
+11,769
+49% +$919K
SPG icon
249
Simon Property Group
SPG
$74.5B
$2.76M 0.07%
14,203
-568
-4% -$110K
BHC icon
250
Bausch Health
BHC
$1.65B
$2.74M 0.07%
27,011
+8,768
+48% +$985K
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.